| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800655 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 10/05/2004 | US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea |
| 10/05/2004 | US6800622 Dna binding, antitumour activity |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | CA2128956C Tricyclic diazepine vasopressin antagonists |
| 09/30/2004 | WO2004083212A1 Process to beta-ketoamide intermediates to dipeptidyl peptidase inhibitors |
| 09/30/2004 | WO2004083211A1 Pyrazolopyrimidine compound and use thereof |
| 09/30/2004 | WO2004083210A1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/30/2004 | WO2004082613A2 2,4-diamino-5-[5’-substituted-benzyl] pyrimidines and 2,4-diamino-6-[5’-substituted-benzyl] quinazolines |
| 09/30/2004 | WO2004082606A2 Fused pyrrole compounds |
| 09/30/2004 | WO2004082577A2 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/30/2004 | WO2004058769A3 Triazolopyridazines as protein kinases inhibitors |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | WO2004021979A3 PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192698 Alzheimer's disease, antidepressants, antihistamines, psychological disorders, bipolar disorders, anticancer agents, cardiovascular disorders, hypotensive agents, antilipemic agents , anticholesterol agents, antiinflammatory agents |
| 09/30/2004 | US20040192696 Antiproliferative agents; antiinflammatory agents; neurodegradative disease; autoimmune disease; viricides |
| 09/30/2004 | US20040192682 1,5-Dihydro-pyrazolo[4,3-c]pyridazin-6-one derivatives; glycogen synthase kinase-3 (CSK) inhibitors; nervous system, psychological, and neurodegenerative disorders; diabetes, psychiatry, multiple sclerosis (MS), myocardial infarction, reperfusion/ischemia, alopecia, and stroke |
| 09/30/2004 | US20040192677 Dna binding, antitumour activity |
| 09/30/2004 | US20040192653 P38 inhibitors and methods of use thereof |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 09/30/2004 | US20040191184 Delivery of muscle relaxants through an inhalation route |
| 09/30/2004 | US20040191183 Delivery of antiemetics through an inhalation route |
| 09/30/2004 | US20040191182 Delivery of analgesics through an inhalation route |
| 09/30/2004 | US20040191181 Vaporization of diphenhydramine from solid for breathing administerig |
| 09/30/2004 | US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches |
| 09/30/2004 | US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support |
| 09/30/2004 | CA2517034A1 Fused pyrrole compounds |
| 09/29/2004 | EP1462450A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 09/29/2004 | EP1461316A2 Synthesis of 2-cyanoziridine-1-carboxamide |
| 09/29/2004 | EP1461042A1 Use of desoxypeganine for treating clinical depression |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461033A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | EP1159272B1 A process for the preparation of 1,4,7,10-tetraazacyclododecane |
| 09/29/2004 | EP1123295B1 Bicyclic nitrogen heterocycles |
| 09/29/2004 | EP1028961B1 Pleuromutilin derivatives as antimicrobials |
| 09/29/2004 | EP0912196B1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 09/29/2004 | EP0820456B1 1,2,4-triazolo 4,3-b]pyridazine derivatives and their use |
| 09/29/2004 | EP0805804B1 Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides |
| 09/29/2004 | EP0804238B1 Method to prevent transplant rejection |
| 09/29/2004 | CN1533394A 6-(2,6-difluorophenyl)-triazolopyrimidines as fungecides |
| 09/29/2004 | CN1533393A Substituted (6-2-tolyl)-triazolopyrimidines as fungicides |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533277A Preventives or remedies for diseases caused by e NOS expression |
| 09/29/2004 | CN1532175A Anti-oxidation single component aromatic hydrocarbon solvent used in copper phthalocyanine synthesis |
| 09/29/2004 | CN1168729C Method for preparing pheophoribide A and pheophytic C by using marine alga |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | WO2004081014A1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 09/23/2004 | WO2004081013A1 Protein kinase inhibitors |
| 09/23/2004 | WO2004081012A1 Antitumor effect potentiator and antitumor agent |
| 09/23/2004 | WO2004081011A1 Immunomodulating heterocyclic compounds |
| 09/23/2004 | WO2004081010A1 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/23/2004 | WO2004081007A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080958A2 Process to tetrahydrotriazolopyrazines and intermediates |
| 09/23/2004 | WO2004080466A1 Cytidine analogs and methods of use |
| 09/23/2004 | WO2004080457A1 Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/23/2004 | WO2004080455A1 Antibacterial agent and anticancer agent |
| 09/23/2004 | WO2004080453A1 Antihepatitis c virus agent and anti-hiv agent |
| 09/23/2004 | WO2004080184A1 Synergistically acting herbicidal mixtures |
| 09/23/2004 | WO2004064721A3 A pyrazolopyrimidine compound and a process for preparing the same |
| 09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 09/23/2004 | WO2004039815A8 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 09/23/2004 | WO2004021989A3 Imidazolopyridines and methods of making and using the same |
| 09/23/2004 | WO2004013300A3 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 09/23/2004 | WO2003103574A3 Protease inhibitors |
| 09/23/2004 | US20040186291 dissolving gases of triethylenediamine in solvents selected form acyclic alcohols-2+ or ethers of these alcohols, then treating with adsorbers such as activated carbon or ion exchangers; purification; storage stability |
| 09/23/2004 | US20040186286 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 09/23/2004 | US20040186285 photosensitizers for therapy of cancer, infections and other diseases as well as for light irradiation treatments in other cases |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186107 Diazabicyclic central nervous system active agents |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186091 Triazole compounds useful in therapy |
| 09/23/2004 | US20040186087 Siderophore conjugates of photoactive dyes for photodynamic therapy |
| 09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
| 09/23/2004 | US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 09/23/2004 | US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices |
| 09/23/2004 | US20040185006 Delivery of stimulants through an inhalation route |
| 09/23/2004 | US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 09/23/2004 | US20040185004 Delivery of erectile dysfunction drugs through an inhalation route |